Toronto Dominion Bank’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
BG
Toronto Dominion Bank's IONS Position: Q4 2025 in Review
Toronto Dominion Bank sold out of Ionis Pharmaceuticals (IONS) in Q4 2025, closing a stake of 951 shares — an estimated $62.2K sold.
Toronto Dominion Bank first reported a position in IONS in Q1 2016 and held it in 15 quarters. The position peaked at $1.41M in Q4 2020. 491 funds tracked by Wall St. Rank hold IONS as of Q4 2025.
- Toronto Dominion Bank reported no remaining Ionis Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Toronto Dominion Bank sold 951 Ionis Pharmaceuticals shares in Q4 2025, an estimated $62.2K.
- Toronto Dominion Bank first reported a position in Ionis Pharmaceuticals in Q1 2016 and held it in 15 quarters.
- Toronto Dominion Bank's Ionis Pharmaceuticals position peaked at $1.41M in Q4 2020.
- 491 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2025.
Based on Toronto Dominion Bank's 13F filing for Q4 2025, filed 17 Feb 2026.